Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Larmonier

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
International Journal of Cancer|October 21, 2003
Freshly isolated bone marrow cells induce death of various carcinoma cell linesNicolas Larmonier, François Ghiringhelli, Claire B Larmonier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Dendritic cells trigger tumor cell death by a nitric oxide-dependent mechanismAlexandra Nicolas, Dominique Cathelin, Nicolas Larmonier, et al.
European Journal of Immunology|February 10, 2004
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeFrançois Ghiringhelli, Nicolas Larmonier, Elise Schmitt, et al.
International Journal of Molecular Medicine|February 10, 2004
Kinetics of tumor cell apoptosis and immune cell activation during the regression of tumors induced by lipid A in a rat model of colon cancerClaire B Larmonier, Laurent Arnould, Nicolas Larmonier, et al.
Inflammatory Bowel Diseases|January 18, 2008
Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependentClaire Billerey-Larmonier, Jennifer K Uno, Nicolas Larmonier, et al.
Apoptosis : an International Journal on Programmed Cell Death|June 2, 2006
Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loadingNicolas Larmonier, Delphine Mérino, Alexandra Nicolas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumorsNicolas Larmonier, Nona Janikashvili, Collin James LaCasse, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10Nicolas Larmonier, Marilyn Marron, Yi Zeng, et al.
European Journal of Immunology|April 30, 2014
PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15Neale T Hanke, Collin J LaCasse, Claire B Larmonier, et al.
Clinical and Vaccine Immunology : CVI|April 3, 2009
Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assayXinchun Chen, Qianting Yang, Mingxia Zhang, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
International Journal of Cancer|October 21, 2003
Freshly isolated bone marrow cells induce death of various carcinoma cell linesNicolas Larmonier, François Ghiringhelli, Claire B Larmonier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
Dendritic cells trigger tumor cell death by a nitric oxide-dependent mechanismAlexandra Nicolas, Dominique Cathelin, Nicolas Larmonier, et al.
European Journal of Immunology|February 10, 2004
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeFrançois Ghiringhelli, Nicolas Larmonier, Elise Schmitt, et al.
International Journal of Molecular Medicine|February 10, 2004
Kinetics of tumor cell apoptosis and immune cell activation during the regression of tumors induced by lipid A in a rat model of colon cancerClaire B Larmonier, Laurent Arnould, Nicolas Larmonier, et al.
Inflammatory Bowel Diseases|January 18, 2008
Protective effects of dietary curcumin in mouse model of chemically induced colitis are strain dependentClaire Billerey-Larmonier, Jennifer K Uno, Nicolas Larmonier, et al.
Apoptosis : an International Journal on Programmed Cell Death|June 2, 2006
Apoptotic, necrotic, or fused tumor cells: an equivalent source of antigen for dendritic cell loadingNicolas Larmonier, Delphine Mérino, Alexandra Nicolas, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Imatinib mesylate inhibits CD4+ CD25+ regulatory T cell activity and enhances active immunotherapy against BCR-ABL- tumorsNicolas Larmonier, Nona Janikashvili, Collin James LaCasse, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2006
Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves TGF-beta and IL-10Nicolas Larmonier, Marilyn Marron, Yi Zeng, et al.
European Journal of Immunology|April 30, 2014
PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15Neale T Hanke, Collin J LaCasse, Claire B Larmonier, et al.
Clinical and Vaccine Immunology : CVI|April 3, 2009
Diagnosis of active tuberculosis in China using an in-house gamma interferon enzyme-linked immunospot assayXinchun Chen, Qianting Yang, Mingxia Zhang, et al.
Pageof 6